Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen Has US Rituximab Nod - But No RA Indication
Riabni Biosimilar Rival To Rituxan Seeks To Compete With Price Discount
Dec 18 2020
•
By
David Wallace
Amgen’s price discount matches that of Pfizer • Source: Shutterstock
More from Products
More from Generics Bulletin